RotaTeq® Rotavirus Vaccine Indicated for Patients 6 to 32 Weeks of Age Solution Single Dose Tube 2 mL

Features

• RotaTeq® is a vaccine indicated for the prevention of rotavirus gastroenteritis caused by types G1, G2, G3, G4, and G9
• RotaTeq is approved for use in infants 6 weeks to 32 weeks of age
• The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals
• Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap, allowing for direct oral administration
• The dosing tube is contained in a pouch
• Package of 25 individually pouched single-dose tubes

More Information

• SDS